PUBLISHER: The Business Research Company | PRODUCT CODE: 1939239
PUBLISHER: The Business Research Company | PRODUCT CODE: 1939239
Aortic stent grafts are medical devices designed to strengthen weakened sections of the aorta, the body's primary blood vessel. They consist of a fabric tube (graft) supported by a metal mesh (stent) and are implanted using minimally invasive procedures to address conditions such as aneurysms affecting the aorta.
Abdominal aortic stent grafts and thoracic aortic stent grafts are the two main types. Abdominal aortic stent grafts specifically target abdominal aortic aneurysms by reinforcing the weakened vessel wall to prevent potential rupture. These devices find application in various settings such as hospitals, ambulatory surgical centers, and outpatient facilities for treating both abdominal and thoracic aortic aneurysms.
Tariffs are influencing the aortic stent grafts market by increasing import and component acquisition costs for metal stent frames, graft fabrics, delivery catheters, and precision engineering parts sourced across cross-border supply chains, which raises manufacturing and procurement costs for hospitals and ambulatory surgical centers. The impact is more pronounced in regions that depend heavily on imported EVAR and TEVAR systems, including emerging Asia-Pacific, Latin America, and parts of Europe. At the same time, tariffs are accelerating localization, supplier diversification, and near-shore manufacturing initiatives, which may support domestic device production and improve long-term supply resilience across both abdominal and thoracic stent graft product segments.
The aortic stent grafts market research report is one of a series of new reports from The Business Research Company that provides aortic stent grafts market statistics, including aortic stent grafts industry global market size, regional shares, competitors with a aortic stent grafts market share, detailed aortic stent grafts market segments, market trends and opportunities, and any further data you may need to thrive in the aortic stent grafts industry. This aortic stent grafts market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The aortic stent grafts market size has grown strongly in recent years. It will grow from $3.59 billion in 2025 to $3.9 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to rising prevalence of abdominal and thoracic aortic aneurysms, early adoption of evar and tevar procedures, growth in vascular surgery infrastructure, increasing availability of endovascular device technologies, growing geriatric population with cardiovascular risk.
The aortic stent grafts market size is expected to see strong growth in the next few years. It will grow to $5.3 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing procedural volumes in ambulatory and outpatient surgical centers, rising demand for hybrid and advanced stent graft systems, expansion of screening programs for aortic aneurysm detection, growing investments in minimally invasive vascular therapy, increasing focus on reducing postoperative complications and hospital stay. Major trends in the forecast period include increasing preference for minimally invasive endovascular repair over open aortic surgery, growing clinical adoption of modular and customizable aortic stent graft designs, rising demand for next-generation graft materials offering greater flexibility and durability, expanding utilization of stent grafts in complex abdominal and thoracic aneurysm cases, increasing shift toward early aneurysm intervention to reduce rupture risk.
The growth of the aortic stent graft market is driven by the increasing prevalence of cardiovascular diseases. Lifestyle factors such as poor diet, lack of exercise, smoking, and rising obesity rates contribute significantly to the rise in cardiovascular disease cases. Aortic stent grafts are crucial in treating cardiovascular conditions by repairing and reinforcing weakened sections of the aorta, particularly in cases of aneurysms. According to the British Heart Foundation, coronary heart disease (CHD) was a leading cause of mortality in the UK in January 2024, responsible for approximately 68,000 deaths annually, translating to one death roughly every eight minutes. This underscores the significant impact of cardiovascular diseases on driving the growth of the aortic stent graft market.
Leading companies in the aortic stent graft market are concentrating on developing advanced products, such as stent-graft systems with enhanced stability, flexibility, and reduced risk of complications. A stent-graft system is a medical device used in endovascular procedures to address aneurysms, featuring a stent for structural support and a graft to reinforce the vessel wall. For example, in August 2024, Terumo India, a medical device company based in India, introduced the TREO Abdominal Stent-Graft System. This advanced endovascular device is designed for the treatment of infrarenal abdominal aortic aneurysms, featuring in situ limb adjustability, improved sealing, and strong fixation to ensure stability and better long-term patient outcomes.
In December 2023, Tekni-Plex Inc. strengthened its position in the healthcare sector by acquiring Seisa Medical, a US-based medical device manufacturer specializing in aortic stent grafts and valve components. This acquisition enhanced TekniPlex Healthcare's capabilities in medical materials science and process technologies, particularly in developing minimally invasive and interventional therapy devices.
Major companies operating in the aortic stent grafts market are Medtronic plc, W.L. Gore & Associates Inc, Terumo Corporation, Cook Medical Inc, Endologix Inc, Lombard Medical Ltd, MicroPort Scientific Corporation, Jotec GmbH, Braile Biomedica, Merit Medical Systems Inc, Endospan Ltd, Lifetech Scientific (Shenzhen) Co Ltd, Biomerics LLC, Bentley InnoMed GmbH, Trivascular Inc, Abbott Laboratories, Becton Dickinson and Company, Biotronik SE & Co KG, Altura Medical Inc, S&G Biotech Inc
North America was the largest region in the aortic stent grafts market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aortic stent grafts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the aortic stent grafts market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The aortic stent grafts market consists of sales of tube aortic stent grafts, bifurcated aortic stent grafts, and aorto-uniiliac aortic stent grafts. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Aortic Stent Grafts Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses aortic stent grafts market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for aortic stent grafts ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The aortic stent grafts market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.